Migraine-Associated Photophobia Appears to Improve After Botulinum Toxin A Injections

Source: Reuters

Photophobia in patients with migraine improves following botulinum toxin A injections, according to results from an observational study, as reported in Reuters.

Photophobia and dry eye symptoms are common in patients with migraine, but few studies have evaluated therapies for these ancillary symptoms.

Dr. Anat Galor from Miami VA Medical Center and colleagues evaluated the potential efficacy of botulinum toxin A (BoNT-A) in reducing photophobia and dry eye symptoms in a retrospective review of 72 patients, all of whom received BoNT-A.

Read the full article.

Related Content